Q32 Bio (QTTB) Preferred Stock Liabilities (2017 - 2023)

Q32 Bio's Preferred Stock Liabilities history runs 3 years deep, the most recent figure standing at $111.4 million for Q4 2023.

• On a quarterly basis, Preferred Stock Liabilities changed N/A year-over-year to $111.4 million in Q4 2023; TTM through Dec 2023 was $111.4 million, a N/A change from a year earlier, with the FY2023 full-year figure at $111.4 million, changed N/A from the prior year.
• Preferred Stock Liabilities slipped to $111.4 million in Q4 2023 per QTTB's latest filing, from $137.8 million in the prior quarter.
• Across five years, Preferred Stock Liabilities topped out at $111.4 million in Q4 2023 and bottomed at $111.4 million in Q4 2023.